Acute Reduction in Left Ventricular Function Following Transcatheter Mitral Edge-to-Edge Repair

Background Little is known about the impact of transcatheter mitral valve edge-to-edge repair on changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction in LVEF on prognosis. We aimed to assess changes in LVEF after transcatheter mitral valve edge-to-edge repair for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Heart Association 2023-07, Vol.12 (13), p.e029735-e029735
Hauptverfasser: Perl, Leor, Kheifets, Mark, Guido, Ascione, Agricola, Eustachio, Denti, Paolo, Wild, Mirjam Gauri, Praz, Fabien, Rubbio, Antonio Popolo, Bedogni, Francesco, De Marco, Federico, Beeri, Ronen, Shuvy, Mony, Melillo, Francesco, Montorfano, Matteo, Freixa, Xavier, de la Fuente Mancera, Juan Carlos, Giordano, Arturo, Finizio, Filippo, Van Mieghem, Nicolas M, Ooms, J F W, Fam, Neil, O'Connor, Cormac, Toggweiler, Stefan, Levi, Amos, Shapira, Yaron, Schwartzenberg, Shmuel, Pidello, Stefano, D'Ascenzo, Fabrizio, Angelini, Filippo, Haberman, Dan, Crimi, Gabriele, Porto, Italo, Cozzi, Ottavia, Giannini, Francesco, Tarantini, Giuseppe, Maisano, Francesco, Kornowski, Ran
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Little is known about the impact of transcatheter mitral valve edge-to-edge repair on changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction in LVEF on prognosis. We aimed to assess changes in LVEF after transcatheter mitral valve edge-to-edge repair for both primary and secondary mitral regurgitation (PMR and SMR, respectively), identify rates and predictors of LVEF reduction, and estimate its impact on prognosis. Methods and Results In this international multicenter registry, patients with both PMR and SMR undergoing transcatheter mitral valve edge-to-edge repair were included. We assessed rates of acute LVEF reduction (LVEFR), defined as an acute relative decrease of >15% in LVEF, its impact on all-cause mortality, major adverse cardiac event (composite end point of all-cause death, mitral valve surgery, and residual mitral regurgitation grade ≥2), and LVEF at 12 months, as well as predictors for LVEFR. Of 2534 patients included (727 with PMR, and 1807 with SMR), 469 (18.5%) developed LVEFR. Patients with PMR were older (79.0±9.2 versus 71.8±8.9 years;
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.123.029735